Clinical Trials
165 trialsSCOUT-1
AstraZeneca
DESCENT-1
A2 Biotherapeutics Inc.
Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance
AstraZeneca
DUOLife
AstraZeneca
DP-04
AstraZeneca
BASECAMP-1
A2 Biotherapeutics Inc.
ELEPHAS-02
Elephas
OLIVIA
AstraZeneca
ENVISION
Exact Sciences Corporation
Evaluation of Improved Onboard Patient Imaging
Varian, a Siemens Healthineers Company
ConFeR
AbbVie
A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice
Takeda
TraveraRTGx
Travera Inc
PROACTION:
PinkDx, Inc.
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
OVAmiARN
ZIWIG
IREN
AstraZeneca
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Carevive Systems, Inc.
FORCE
AbbVie
SMARAGD
iOMEDICO AG
EXoPERT EMERALD Clinical Study
EXoPERT
CAMPERR
Adela, Inc
SCORE
Natera, Inc.
ELEPHAS-05
Elephas
CCANED-CIPHER
Dysplasia Diagnostics Limited
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
TScan Therapeutics, Inc.
HERGYN
Daiichi Sankyo
Clinical Pre-screening Protocol for Ovarian Cancer
Allarity Therapeutics
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients
AstraZeneca
OVAL-1
AstraZeneca
Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations
MiMARK Diagnostics, S.L.
Development of a Molecular Diagnostic Tool for Endometrial Cancer.
MiMARK Diagnostics, S.L.
ORACLE
Guardant Health, Inc.
OLAP
AstraZeneca
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Alaunos Therapeutics
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Alaunos Therapeutics
RETRACE
MSD Italia S.r.l.
OVARD
AstraZeneca
START
Lyell Immunopharma, Inc.
Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World Setting
AstraZeneca
CYCLE_ENDO
Cycle Therapeutics Ltd
BARHYSTER
Aesculap AG
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer
Pfizer
A Multicenter Cancer Biospecimen Collection Study
Cofactor Genomics, Inc.
PREFER
Labcorp Corporation of America Holdings, Inc
ChemoINtel
Pierian Biosciences
INSPIRE
Singlera Genomics Inc.
A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass
Cleo Diagnostics Ltd